Involvement of 5-HT(1B/1D) and 5-HT(2A) receptors in 5-HT-induced contraction of endothelium-denuded rabbit epicardial coronary arteries

British Journal of Pharmacology

Volumn 122, Issue 5, 1997, Pages 875-884

  Ellwood, Amanda J ^a   Curtis, Michael J ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

( ) methyl 5 hydroxytryptamine; 5 Carboxamidotryptamine; 5 HT; 5 HT(1B) receptor; 5 HT(1D) receptor; 5 HT(2A) receptor; Coronary artery; Endothelium; GR127935; Sumatriptan

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 5 CARBAMOYLTRYPTAMINE; ALPHA METHYLSEROTONIN; KETANSERIN; N [4 METHOXY 3 (4 METHYL 1 PIPERAZINYL)PHENYL] 2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL)[1,1' BIPHENYL] 4 CARBOXAMIDE; SEROTONIN; SEROTONIN 1B RECEPTOR; SEROTONIN 1D RECEPTOR; SEROTONIN 2A RECEPTOR; SUMATRIPTAN;

ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; CORONARY ARTERY; DRUG ANTAGONISM; NONHUMAN; PRIORITY JOURNAL; RABBIT;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ANIMALS; CORONARY VESSELS; ENDOTHELIUM, VASCULAR; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; OXADIAZOLES; PERICARDIUM; PIPERAZINES; RABBITS; RECEPTOR, SEROTONIN, 5-HT1B; RECEPTOR, SEROTONIN, 5-HT1D; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SUMATRIPTAN; VASOCONSTRICTOR AGENTS;

EID: 0030772954     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701470     Document Type: Article

References (66)

1. 1Dβ receptor. Mol. Pharmacol., 41, 1-7.
2. APPERLY, E., HUMPHREY, P.P.A. & LEVY, G.P. (1976). Receptors for 5-HT and noradrenaline in rabbit isolated ear artery and aorta. Br. J. Pharmacol., 58, 215-224.
3. ARUNLAKSHANA, O. & SCHILD, H.O. (1959). Some quantitative uses of drug antagonists. Br. J. Pharmacol., Chemother., 14, 48-58.
4. AWANO, K., YOKOYAMA, M. & FUKUZAKI, H. (1989). Role of serotonin, histamine, and thromboxane A2 in platelet-induced coronary arteries and aortae from rabbits. J. Cardiovasc. Pharmacol., 13, 781-792.
5. 1D receptor subtypes. Naunyn-Schmiedeherg's Arch. Pharmacol., 354, 237-244.
6. 1D-like receptors, a comparison with grafted veins. Naunyn-Schmiedeberg's Arch. Pharmacol., 345, 500-508.
7. 2 receptor subtypes: a family reunited? Trends Pharmacol. Sci., 16, 105-110.
8. BORMAN, R.A. & BURLEIGH, D.E. (1995). Characterisation of the 5- HT receptor mediating contraction of the circular muscle of human small intestine. Br. J. Pharmacol., 116, 261P.
9. 1D receptors. In Experimental Headache Models, ed. Oleson, J & Moskowitz, M.A. pp. 125-148. New York: Raven Press.
10. 2 and 5-hydroxytryptamine receptor subtypes in human coronary arteries. Circulation, 87, 874-880.
11. 1D antagonists. J. Med. Chem., 37, 2253-2257.
12. CUSHING, D.J. & COHEN, M.L. (1992). Comparison of serotonin receptors that mediate smooth muscle contraction in canine and porcine coronary artery. J. Phamacol. Exp. Ther., 261, 856-862.
13. 1D receptors of 5-hydroxytryptamine-induced contractions of rabbit middle and posterior cerebral arteries. Br. J. Pharmacol., 112, 939-945.
14. ELLWOOD, A.J. & CURTIS, M.J. (1994). A protocol for preventing endothelium dependent coronary vasodilatation in rabbit isolated heart using saponin. Br. J. Pharmacol., 113, 178P.
15. ELLWOOD, A.J. & CURTIS, M.J. (1996a). Mechanism of 5-hydroxytryptamine-induced coronary vasodilatation assessed by direct detection of nitric oxide production in guinea pig isolated heart. Br. J. Pharmacol. 119, 721-729.
16. ELLWOOD, A.J. & CURTIS, M.J. (1996b). Mechanism of actions of sumatriptan on coronary flow before and after endothelial dysfunction in guinea pig isolated heart. Br. J. Pharmacol., 120, 1039-1048.
17. ELLWOOD, A.J. & CURTIS, M.J. (1996c). The mesulergine-sensitive increase in coronary blood flow evoked by sumatriptan in GR127935-treated guinea-pig isolated hearts is caused by NO released from coronary endothelium. Br. J. Pharmacol., 118, 81P.
18. 2. Circ. Res., 66, 1427-1435.
19. FELETOU, M. & TEISSERIE, B. (1992). Vascular pharmacology of the micro-pig: Importance of the endothelium. In Swine as Models in Biochemical Research, ed. Swindle, M., Moody, D.C. & Phillips, L.D., pp. 74-95. Ames: Iowa State Press.
20. FELETOU, M., DELLAZUANA, O. & DUHAULT, J. (1994). Serotoninergic receptor subtype in coronary artery smooth muscle from young and atherosclerotic rabbit. J. Pharmacol. Exp. Ther., 268, 124-132.
21. FENUIK, W., HUMPHREY, P.P.A. & PERREN, M.J. (1989). The selective carotid arterial vasoconstrictor action of GR 43175 in anaesthetised dogs. Br. J. Pharmacol., 96, 83-90.
22. 1C-like receptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 347, 471-477.
23. GOLINO, P., PISCIONE, F., WILLERSON, J.T., CAPELLI-BIGAZZI, M., FOCACCIO, A., VILLARI, B., INDOLFI, C., RUSSOLI, E., CONDORELLI, M. & CHIARELLO, M. (1991). Divergent effects of serotonin on coronary artery dimensions and blood flow in patients with coronary atherosclerosis and control patients. New Eng. J. Med., 324, 641-648.
24. 14C serotonin in platelets following incubation of platelet-rich with EDTA. Thromb. Res., 14, 981-986.
25. 1D subtype. Br. J. Pharmacol., 106, 703-709.
26. 1D-like pharmacological specificity. Biochem. Biophys. Res. Commun., 184, 752-759.
27. 1D receptor subtypes. Trends Pharmacol. Sci., 17, 103-105.
28. 1Dβ receptors. FEBS Lett., 377, 73-76.
29. HEISTAD, D.D., ARMSTRONG, M.L., MARCUS, M.L., PIEGORS, D.J. & MARK, A.L. (1984). Augmented response to vasoconstrictor stimuli in hyper-choleseterolemic and atherosclerotic rabbits. Circ. Res., 54, 711-718.
30. HILLIS, D.L. & LANGE, R.A. (1991). Serotonin and acute ischemic heart disease. New Engl. J. Med., 324, 688-689.
31. HOYER, D., CLARKE, D.E., FOZARD, J.R., HARTIG, P.R., MARTIN, G.R., MYLECHARANE, E.J., SAXENA, P.R. & HUMPHREY, P.P.A. (1994). VII. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev., 46, 157-204.
32. 1-like receptor in dog isolated saphenous vein. Br. J. Pharmacol., 94, 1123-1132.
33. HUMPHREY, P.P.A., FENUIK, W. & WATTS, A.D. (1982). Ketanserin - an antihypertensive drug? J. Pharm. Pharmacol., 35, 541-545.
34. 2 binding profiles of the serotonin agents alphamethylserotonin and 2-methylserotoadnf7j05 nin. J. Med. Chem., 33, 755-759.
35. 1Dβ receptors. Circulation, 90, 1141-1153.
36. KAUMANN, A.J., PARSONS, A.A. & BROWN, A.M. (1993). Human arterial constrictor receptors. Cardiovasc. Res., 27, 2094-2103.
37. 2-like receptors. Can they be classified with the available antagonists? Br. J. Pharmacol., 88, 585-589.
38. LIU, Y., HARDER, D.R. & LOMBARD, J.H. (1994). Myogenic activation of small canine renal arteries after nonchemical removal of the endothelium. Am. J. Physiol., 267, H302-H307.
39. LUCAS, J.J. & HEN, R. (1995). New players in the 5-HT receptor field: genes and knockouts. Trends Pharmacol. Sci., 16, 246-252.
40. 1-like receptor in sheep coronary arteries. J. Vasc. Med. Biol., 1, 185-189.
41. MARTIN, G.R., LEFF, P., CAMBRIDGE, D. & BARRETT, V.J. (1987). Comparative analysis of two types of 5-hydroxytryptamine receptor mediating vasorelaxation: differential classification using tryptamines. Naunyn-Schmiedeberg's Arch. Pharmacol., 336, 365-373.
42. MCFADDEN, E.P., BAUTERS, C., LABLANCHE, J.M., QUANDALLE, P., LEROY, F. & BERTRAND, M.E. (1993). Response of human coronary arteries to serotonin after injury by coronary angioplasty. Circulation, 88, 2076-2085.
43. 2 receptors. In: Cardiovascular Pharmacology of 5-Hydroxytryptamine, Prospective Therapeutic Applications. ed. Saxena, P.R., Wallis, D.I., Wouters, W. & Bevan, P. pp. 82-100. Dordrecht, Netherlands: Kluwer Academic Press.
44. NYBORG, N.C.B. (1991). Ageing is associated with increased receptor affinity and decreased receptor reserve in rat isolated coronary arteries. Br. J. Pharmacol., 102, 282-286.
45. 1Dβ receptor gene. Biochem. Pharmacol., 50, 1651-1658.
46. 1B receptors. Eur. J. Pharmacol. Mol. Pharmacol., 290, 95-103.
47. 1Dβ receptors mediating inhibition of cAMP in permanently transfected CHO-KI cells: pharmacological agonists and antagonists. Cell Pharmacol., 2, 49-57.
48. 1D binding sites. Eur. J. Pharmacol., 163, 133-136.
49. RAZZAQUE, Z., LONGMORE, J. & HILL, R.G. (1995). Differences in the effects of ketanserin and GR127935 on receptor mediatied response in rabbit saphenous vein and guinea-pig jugular vein. Eur. J. Pharmacol., 283, 199-206.
50. 1-like receptors mediate 5-hydroxytryptamine-induced contraction of guinea-pig isolated guinea-pig iliac artery. Br. J. Pharmacol., 102, 386-390.
51. 1D receptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 340, 135-138.
52. 1D receptor subtype. J. Pharmacol. Exp. Ther., 252, 387-395.
53. 1D receptor antagonist. Behav. Brain Res., 73, 157-161.
54. 1D receptor antagonist. Br. J. Pharmacol., 112, 9P.
55. STEWART, D.J., MUNZEL, T. & BASSENGE, E. (1987). Reversal of acetylcholine-induced coronary resistance vessel dilation by hemoglobin. Eur. J. Pharmacol., 136, 239-242.
56. TADIPATRI, S., VAN HEUVEN-NOLSEN, D., FENUIK, W. & SAXENA, P.R. (1991). Analysis of the 5-HT receptors mediating contractions in the rabbit isolated renal artery. Br. J. Pharmacol., 104, 887-894.
57. TAYLOR, J.D., WYKES, A.A., GLADISH, Y.C. & MARTIN, W.B. (1974). New inhibitor of monoamine oxidase. Nature, 187, 4741-4742.
58. 1-like receptor mediating contraction of canine coronary artery. Eur. J. Pharmacol., 300, 109-112.
59. TODA, N. & OKOMURA, T. (1990). Comparison of response to 5- carboxamidotryptamine and serotonin in isolated human, monkey and dog coronary arteries. J. Pharmacol. Exp. Ther., 253, 676-682.
60. 2 serotinergic receptors. J. Pharmacol. Exp. Ther., 218, 217-230.
61. 2 receptor blockade restores vasodilatation to 5-HT in atherosclerotic rabbit hearts: Role of the endothelium. J. Cardiovasc. Pharmacol., 17, Supp 3, S222-S228.
62. 2 serotoninergic vasoconstriction in hypercholesterolemic rabbits. In Endothelium Derived Contracting Factor, ed. Rubanyi, G.M. & Vanhoutte, P.M. pp. 162-168. Basel: J. Karger.
63. 1Dβ receptors. Br. J. Pharmacol., 114, 363P.
64. 1Dβ. Proc. Natl. Acad. Sci. U.S.A., 89, 3630-3634.
65. 1D subtypes. Naunyn-Schmideberg's Arch. Pharmacol., 354, 226-236.
66. 1Dβ receptor subtypes. Eur. J. Pharmacol. Mol. Pharmacol., 291, 9-15.